Research
Advantage

Global education thought-leader, Laureate Professor Jenny Gore has been conferred the prestigious title of Visiting Professor at Oxford University, commencing October 2018.

The Australian Research Council (ARC) announced University of Newcastle Senior Deputy Vice-Chancellor (Research and Innovation), Professor Kevin Hall has been appointed a member of its Advisory Council.

Internationally-recognised leader in Indigenous cancer research, Professor Gail Garvey, will share her insights on the role Indigenous medical education can play in improving the health outcomes of Indigenous Australians, in a keynote lecture at UON tonight.

Researchers from the University of Newcastle have received $582,361 from the Australian Government to address interpersonal violence in the lives of young people.

Researchers in occupational therapy at UON are exploring how responses to sensory stimuli may affect the experience of or recovery from an eating disorder

University of Newcastle’s Professor Craig Pennell, is the newly appointed Chair of the Red Nose National Scientific Advisory Group.

Conjoint Professor David Durrheim has received $1.48 million in funding under the Australian Government’s Health Security Initiative for the Indo-Pacific, designed to strengthen health security throughout Southeast Asia and the Pacific.

Cardiovascular disease risk in kids due to poor aerobic fitness has been cut by more than half in primary schools using a new online physical activity training program for teachers.

Professor Tania Sourdin (Newcastle Law School), Dr Jamie Carlson (Newcastle Business School), Emeritus Professor Martin Watts, and Ms Christine Armstrong (PhD Candidate) have found that return on investment in complaint handling can be as high as 1000%.

World-leading pharmaceutical company MSD (Merck in the US), has acquired virotherapy firm, Viralytics, founded in Newcastle by Associate Professor Darren Shafren.

The Research Grants and Ethics Management system (RIMS) is undertaking a major upgrade.

Current chemotherapy and radiation treatment options for breast cancer patients are grueling, and not all patients see positive results, however with funding raised from the 2018 Pink Frangipani Ball, Dr Nikki Verrills and her research team hope to develop rev